Comercio Excelente, through its predecessors in interest, started distributing Van Heusen, Calvin Klein and Geoffrey Beene dress shirts manufactured by PVH in 2006. Since then the partnership with PVH has grown significantly, and now, Comercio Excelente and its affiliated entities distribute PVH’s dress shirts under numerous labels including: Calvin Klein, Van Heusen, IZOD, Geoffrey Beene, Arrow, DKNY, Michael Michael Kors, Michael Kors, Chaps, Donald J. Trump Signature Collection, Joseph Abboud, Joe by Joseph Abboud, Kenneth Cole and Kenneth Cole Reaction. Comercio Excelente also currently distributes PVH’s neckwear, underwear, sleepwear and loungewear under a number of these brands.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: Forward-looking statements made in this press release, including, without limitation, statements relating to PVH Corp.’s future plans, strategies, objectives, expectations and intentions, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with accuracy, and some of which might not be anticipated, including, without limitation, the following: (i) the Company's plans, strategies, objectives, expectations and intentions are subject to change at any time at the discretion of the Company; (ii) the levels of sales of the Company's licensees at wholesale and retail, and the extent of discounts and promotional pricing in which the Company's licensees and other business partners are required to engage, all of which can be affected by weather conditions, changes in the economy, fuel prices, reductions in travel, fashion trends, consolidations, repositionings and bankruptcies in the retail industries, and other factors; (iii) civil conflict, war or terrorist acts, the threat of any of the foregoing, or political and labor instability in any of the countries where the Company's licensees' or other business partners' products are sold, produced or are planned to be sold or produced; (iv) disease epidemics and health related concerns, which could result in closed factories, reduced workforces, scarcity of raw materials and scrutiny or embargoing of goods produced in infected areas, as well as reduced consumer traffic and purchasing, as consumers limit or cease shopping in order to avoid exposure or become ill; (v) the failure of the Company's licensees to market successfully licensed products or to preserve the value of the Company's brands, or their misuse of the Company's brands and (vi) other risks and uncertainties indicated from time to time in the Company's filings with the Securities and Exchange Commission.